PS

Prasanta Saha

Active Director Director DIN 10522419
DIN 10522419 First appointment Feb 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Prasanta Saha

Data last updated:

Prasanta Saha is a Director at Elmeric Bioscience Private Limited (since 2024). The company operates in Pharma.

DIN 10522419
Primary Designation Director
Industry Pharma
First Appointment 26 Feb 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Elmeric Bioscience Private Limited U46497KA2024PTC185306
Director26 Feb 20242024Active

Board colleagues of Prasanta Saha

Directorship timeline

Open interactive timeline →
Elmeric Bioscience Private Limited
Premium access

Shareholding and investment profile for Prasanta Saha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prasanta Saha

Prasanta Saha currently holds 1 directorship: Elmeric Bioscience Private Limited (Director, since 26 Feb 2024).

Prasanta Saha was first appointed on 26 Feb 2024 as Director at Elmeric Bioscience Private Limited.

The current boards of Prasanta Saha's companies include Rakesh Saha (Elmeric Bioscience Private Limited), Sujoy Kar (Elmeric Bioscience Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available